References
- Barnholtz-Sloan JS, Courtney K, Carol K, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol. 2016;18(suppl_5), v1–v75 .
- Dorfer C, Tonn J, Rutka JT. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options. Handb Clin Neurol. 2016;134:417.
- Roberta R, Guido R, Didier F, et al. EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol, 2017;14228–14250.
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820.
- Romoli S, Abbruzzese A, Castagna M, et al. Unusual exophytic subependymoma in the bulbo-cerebellar angle. Case report. J Neurosurg Sci. 2007;51:81–84.
- Scheinker I. Subependymoma: a newly recognized tumor of subependymal derivation. J Neurosurg. 1945;2:232–240.
- Nishio S, Morioka T, Mihara F, et al. Subependymoma of the lateral ventricles. Neurosurg Rev. 2000;23:98–103.
- Ragel BT, Osborn AG, Whang K, et al. Couldwell WT: subependymomas: an analysis of clinical and imaging features. Neurosurgery. 2006;58:881–890.
- Huang Y. Subependymoma with extensive microcystic transformation: a case report. Int J Clin Exp Pathol. 2015;8:2191–2194.
- Kim H-C, Kim I-O, Kim CJ. Subependymoma in the third ventricle in a child. Clin Imaging. 2004. DOI:10.1016/S0899-7071(03)00203-1
- Jain A, Amin AG, Jain P, et al. Subependymoma: clinical features and surgical outcomes. Neurol Res. 2012;34:677–684.
- Natrella F, Mariottini A, Rocchi R, et al. Supratentorial neurenteric cyst associated with a intraparenchymal subependymoma. BMJ Case Rep. 2012. DOI:10.1136/bcr.01.2012.5566
- Lin Y, Jea A, Melkonian SC, et al. Treatment of pediatric Grade II spinal ependymomas: a population-based study. J Neurosurg Pediatr. 2015;15:1–7.
- Go KO, Lee M, Lim Y, et al. A rare case of intraparenchymal subependymoma in a child. Childs Nerv Syst. 2020;37:1759–1764.
- Harrell FJ, Margolis PA, Gove S, et al. Development of a clinical prediction model for an ordinal outcome: the World Health Organization multicentre study of clinical signs and etiological agents of Pneumonia, Sepsis and Meningitis in young infants. WHO/ARI young infant multicentre study group. Stat Med. 1998;17:909–944.
- Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–e180.
- Collins GS, Le Manach Y. Nomograms need to be presented in full. Cancer-Am Cancer Soc. 2017;123:177–178.
- Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003;22:3515–3525.
- Bi Z, Ren X, Zhang J, et al. Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. J Neurosurg. 2015;122:49–60.
- Varma A, Giraldi D, Mills S, et al. Surgical management and long-term outcome of intracranial subependymoma. Acta Neurochir. 2018;160:1793–1799.
- Claus EB, Calvocoressi L, Bondy ML, et al. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg. 2013;118:649–656.
- Norden AD, Ligon KL, Hammond SN, et al. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology. 2015;84:280–286.
- Rushing EJ, Cooper PB, Q, et al. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neuro-Oncol. 2007;85:297–305. doi:10.1007/s11060-007-9411-6.
- Landriel F, Besada C, Migliaro M, et al. Atypical hemorrhagic presentation of a fourth ventricle subependymoma: case report. Neurol Med Chir. 2013;53:828–831.
- Zhang Q, Xie SN, Wang K, et al. intratumoral hemorrhage as an unusual manifestation of intracranial subependymoma. World Neurosurg. 2018;114: e647–e653.